Search Results - "Rolleri, Robert L"

Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis by Sandborn, William J, Bosworth, Brian, Zakko, Salam, Gordon, Glenn L, Clemmons, David R, Golden, Pamela L, Rolleri, Robert L, Yu, Jing, Barrett, Andrew C, Bortey, Enoch, Paterson, Craig, Forbes, William P

“…Background & Aims Budesonide is a high-potency, second-generation corticosteroid designed to minimize systemic adverse consequences of conventional…”
Get full text

Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users by Schoedel, Kerri A, Rolleri, Robert L, Faulknor, Janice Y, Pixton, Glenn C, Chen, Nancy, Bass, Almasa, Sommerville, Kenneth W, Sellers, Edward

“…To evaluate the pharmacodynamic effects (subjective and physiologic) of a new formulation of immediate release oxycodone HCl (IRO-A; Oxecta™) tablets compared…”
Get more information

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis by Rubin, David T., Sandborn, William J., Bosworth, Brian, Zakko, Salam, Gordon, Glenn L., Sale, Mark E., Rolleri, Robert L., Golden, Pamela L., Barrett, Andrew C., Bortey, Enoch, Forbes, William P.

“…Background Budesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the…”
Get full text

Sa1195 Patient Reported Outcome Measures Derived From the Crohn's Disease Activity Index: Correlation Between PRO2 and PRO3 Scores and CDAIDefined Clinical Thresholds by Khanna, Reena, D'Haens, Geert R, Feagan, Brian G, Sandborn, William, Vandervoort, Margaret K, Zou, Guangyong, Rolleri, Robert L, Paterson, Craig, Forbes, William P, Bortey, Enoch, Levesque, Barrett G

Get full text

Mo1173 Safety Analysis of Budesonide Foam for Inducing Remission in Active Mild to Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis: Data From Two Randomized, Placebo-Controlled Trials by Rubin, David T, Sandborn, William, Bosworth, Brian P, Zakko, Salam F, Gordon, Glenn L, Rolleri, Robert L, Golden, Pamela, Barrett, Andrew, Bortey, Enoch, Forbes, William P

Get full text

Randomized, double-blind, placebo-controlled and active-controlled study to assess the relative abuse potential of oxycodone HCl-niacin tablets compared with oxycodone alone in nondependent, recreational opioid users by Webster, Lynn R, Rolleri, Robert L, Pixton, Glenn C, Sommerville, Kenneth W

“…Abuse-deterrent formulations attempt to address public health and societal concerns regarding opioid abuse. Oxycodone HCl-niacin tablets combine oxycodone HCl…”
Get full text

Pharmacokinetics and pharmacodynamics of a new cardiotonic vasodilator agent, 349U85, in normal subjects by Clifton, G D, Harrison, M R, Wermeling, D P, Long, R A, Fleck, R J, Rolleri, R L, Weller, S, Brown, A R, Welch, R M

“…To assess the pharmacodynamics and pharmacokinetics of single oral doses of a new vasodilator-cardiotonic agent, 349U85 hydrochloride…”
Get more information